+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Seborrhea Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767854
  • Report
  • April 2019
  • Region: Global
  • 49 pages
  • VPA Research

FEATURED COMPANIES

  • Aclaris Therapeutics Inc
  • Astion Pharma A/S
  • Dermapharm AG
  • GlaxoSmithKline Plc
  • Maruho Co Ltd
  • Novartis AG
The global clinical trial report- “2019 Seborrhea Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Seborrhea. It presents in-depth analysis of Seborrhea clinical trials across markets and companies. The research work is for providing complete understanding into trends in Seborrhea.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Seborrhea clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Seborrhea

The research work is prepared through extensive and continuous research on Seborrhea trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Seborrhea patients are identified
  • The report includes panorama of Seborrhea clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Seborrhea clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aclaris Therapeutics Inc
  • Astion Pharma A/S
  • Dermapharm AG
  • GlaxoSmithKline Plc
  • Maruho Co Ltd
  • Novartis AG
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Seborrhea Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Seborrhea Clinical Trials by Region
2.2.2 Average Enrollment of Seborrhea Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Seborrhea Treatment, 2019

3. Region wise Seborrhea Clinical Trials
3.1 Asia Pacific Seborrhea Clinical Trials by Country
3.2 Europe Seborrhea Clinical Trials by Country
3.3 North America Seborrhea Clinical Trials by Country
3.4 Middle East and Africa Seborrhea Clinical Trials by Country
3.5 South and Central America Seborrhea Clinical Trials by Country

4. Seborrhea Clinical Trial Trends
4.1 Start Year wise Seborrhea Clinical Trials
4.2 Phase wise Seborrhea Clinical Trials
4.3 Trial Status wise Seborrhea Clinical Trials
4.4 Trial Type wise Seborrhea Clinical Trials

5. Seborrhea Average Enrollment Trends
5.1 Average Enrollment in Seborrhea Trials by Year
5.2 Average Enrollment in Seborrhea Trials by Phase
5.3 Average Enrollment in Seborrhea Trials by Status
5.4 Average Enrollment in Seborrhea Trials by Type of Trial

6. Companies Participating in Seborrhea Clinical Trials
6.1 Seborrhea Trials by Sponsor Type
6.2 Seborrhea Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Seborrhea Trials- Phase 1
7.2 Seborrhea Trials- Phase 2
7.3 Seborrhea Trials- Phase 3
7.4 Seborrhea Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Seborrhea Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Seborrhea Clinical Trials and Enrolment
Figure 5: Europe - Country wise Seborrhea Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Seborrhea Clinical Trials and Enrolment
Figure 7: North America - Country wise Seborrhea Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Seborrhea Clinical Trials and Enrolment
Figure 9: Seborrhea Clinical Trials by Phase
Figure 10: Seborrhea Clinical Trials by Trial Status
Figure 11: Seborrhea Clinical Trials by Type
Figure 12: Seborrhea Clinical Trials by Sponsor Type
Figure 13: Seborrhea Clinical Trials by Leading Sponsors
Figure 14: Seborrhea Average Enrollment by Phase
Figure 15: Seborrhea Average Enrollment by Trial Status
Figure 16: Seborrhea Average Enrollment by Type
Figure 17: Seborrhea- Average Enrolment by Type of Sponsors
Figure 18: Seborrhea- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Seborrhea Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Seborrhea Clinical Trials and Enrolment
Table 5: Europe - Country wise Seborrhea Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Seborrhea Clinical Trials and Enrolment
Table 7: North America - Country wise Seborrhea Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Seborrhea Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Seborrhea Average Enrollment by Phase
Table 15: Seborrhea Average Enrollment by Trial Status
Table 16: Seborrhea Average Enrollment by Type
Table 17: Seborrhea- Average Enrolment by Type of Sponsors
Table 18: Seborrhea- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
  • A. Menarini Industrie Farmaceutiche
  • Aclaris Therapeutics Inc
  • Astion Pharma A/S
  • Dermapharm AG
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd
  • Maruho Co Ltd
  • Novartis AG
  • Pierre Fabre Foundation
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown
Adroll
adroll